NephroCheck检测系统预测烧伤患者死亡或透析风险的研究
该前瞻性研究纳入2016年3月至2018年4月收治于美国陆军外科研究所烧伤ICU的69例烧伤患者,留取尿液用NephroCheck检测。15例(21.7%)在留尿后30天内达到死亡或需肾脏替代治疗的复合结局,其NephroCheck评分更高(离心P=0.06,非离心P=0.04)。非离心评分在校正分析中不显著,但特异度和阳性预测值较高。
要点
- 烧伤患者留尿后30天内死亡或需RRT的复合结局发生率为21.7%。
- 复合结局患者NephroCheck非离心评分显著更高(P=0.04)。
- 离心与非离心评分高度一致(R2=0.97,P<0.0001)。
核心结论
- NephroCheck评分在发生死亡或需RRT复合结局的烧伤患者中更高,其敏感性和特异性与肌酐及TBSA相当。
研究设计与样本
- 前瞻性队列研究,纳入美国陆军外科研究所烧伤ICU于2016年3月至2018年4月收治的69例烧伤患者。
主要发现
- 69例患者中15例(21.7%)在留尿后30天内达到死亡或需RRT的复合结局。
- 复合结局患者NephroCheck离心评分P=0.06,非离心评分P=0.04。
- 离心与非离心评分高度一致且相关(R2=0.97,P<0.0001)。
- 非离心评分在未校正分析中显著,校正分析中不显著。
临床怎么用
- NephroCheck或可作为烧伤患者死亡或需RRT风险的辅助预测工具,但需进一步验证。
局限性
- 样本量较小(69例),复合结局事件数少(15例)。
- 非离心评分在校正分析中未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute kidney injury (AKI) is associated with high mortality in burn patients. Urinary biomarkers can aid in the prediction of AKI and its consequences, such as death and the need for renal replacement therapy (RRT). The purpose of this study was to investigate a novel methodology for detecting urinary biomarkers, the NephroCheck® Test System, and assess its ability to predict death or the need for RRT in burn patients. Burn patients admitted to the United States Army Institute of Surgical Research (USAISR) burn intensive care unit were prospectively enrolled between March 2016 and April 2018. A urine sample was obtained from all study participants using the NephroCheck® system. Patient and injury characteristics were gathered, and descriptive statistics were calculated and multivariable logistic regression analyses were performed using these data. Of the 69 patients in this study, 15 patients (21.7%) attained the composite outcome of death or needing RRT within 30 days of urine collection. NephroCheck® scores were higher for patients with the composite outcome, with P = 0.06 for centrifuged scores and P = 0.04 for noncentrifuged scores. Centrifuged and noncentrifuged scores were in high agreement and correlation (R2 = 0.97, P < 0.0001). Noncentrifuged scores were significant in the unadjusted analysis, but they were not significant in the adjusted analysis. Although these scores had a lower sensitivity and negative predictive value compared with other parameters, they had the second highest specificity and positive predictive value. NephroCheck® scores were higher in burn patients with the composite outcome of death or needing RRT, and they demonstrated comparable sensitivity and specificity to creatinine and TBSA.
引用
- Suresh MR, Rizzo JA, Sosnov JA, et al. Assessing the NephroCheck® Test System in Predicting the Risk of Death or Dialysis in Burn Patients. J Burn Care Res. 2020. PMID: 31960038. doi:10.1093/jbcr/iraa008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。